Impact of TP53, KRAS, and APC Mutations on Neoadjuvant Chemotherapy Outcomes in Locally Advanced Rectal Cancer.
Takeda T, Shonaka T, Tanino M, Enomoto K, Mizukami S, Otani M, Ohara M, Tani C, Hasegawa K, Ishii T, Sugitani A, Maeda C, Ono Y, Uno Y, Tamamura N, Chiba SI, Mizukami Y, Yokoo H.
Takeda T, et al. Among authors: tanino m.
Cancer Sci. 2025 Nov;116(11):3160-3170. doi: 10.1111/cas.70187. Epub 2025 Sep 10.
Cancer Sci. 2025.
PMID: 40928069
Free PMC article.